Lenalid 15mg Capsules – Lenalidomide 15mg

Lenalid 15mg Capsules contain Lenalidomide 15mg, an immunomodulatory prescription medicine used in the management of certain haematological conditions. Lenalidomide affects immune-system activity and other biological processes involved in specific blood-related disorders. Its use requires specialist medical supervision, appropriate patient assessment and regular monitoring.

This page provides general pharmaceutical product information for healthcare professionals, eligible institutions and authorised pharmaceutical trade partners.

Lenalid 15mg Capsules – Product Specifications

Brand Name: Lenalid

Generic Name: Lenalidomide

Strength: 15mg

Dosage Form: Oral capsules

Therapeutic Category: Immunomodulatory medicine

Manufacturer: Natco Pharma

Packaging: 30 capsules in a bottle

Product composition, manufacturer and packaging information should be verified against the current approved product label and manufacturer's documentation before supply.

About Lenalidomide 15mg

Lenalidomide belongs to a group of medicines known as immunomodulatory agents. It is used in specific haematological treatment protocols, including certain cases of multiple myeloma and myelodysplastic syndromes, depending on the applicable product approval and clinical indication.

Lenalid 15mg Capsules contain 15mg of Lenalidomide per capsule. The strength indicates the quantity of active pharmaceutical ingredient in each capsule; it does not represent a standard dose or treatment recommendation for every patient.

Treatment decisions depend on the patient's diagnosis, kidney function, blood-cell counts, medical history and the treating specialist's assessment.

Therapeutic Information and Clinical Considerations

Lenalidomide may be prescribed alone or alongside other medicines, depending on the approved indication and treatment protocol. Before treatment, healthcare professionals assess relevant clinical factors and review the applicable prescribing information.

During treatment, monitoring may include complete blood counts and kidney-function assessments. The frequency of monitoring and any treatment modifications are determined by the treating specialist according to the patient's clinical condition and approved product guidance.

Important Safety Information

Lenalidomide has potentially serious safety risks and must be used under appropriate medical supervision.

1. Embryo-Fetal Toxicity: Lenalidomide can cause severe birth defects or harm to an unborn baby. Strict pregnancy-prevention precautions and required testing must be followed according to the applicable prescribing information and safety requirements.

2. Haematological Toxicity: Treatment may cause neutropenia, thrombocytopenia and other reductions in blood-cell counts. Regular blood tests, including complete blood counts, are important during treatment.

3. Risk of Blood Clots: Venous and arterial thromboembolic events, including deep vein thrombosis and pulmonary embolism, have been reported. Individual risk assessment and appropriate preventive measures should be determined by the treating specialist.

4. Other Adverse Reactions: Fatigue, gastrointestinal disturbances, skin reactions and other adverse effects may occur. Patients should report unexpected or serious symptoms to their healthcare professional.

Patients should never independently start, stop or modify Lenalidomide treatment.

Dosage and Administration

Lenalid 15mg Capsules must be taken only according to a qualified specialist's prescription and the applicable approved prescribing information. The appropriate regimen depends on the medical indication, kidney function, blood counts, combination therapy and individual patient requirements. The 15mg capsule strength should not be interpreted as a recommended dose for all patients.

Storage and Handling

Store Lenalid Capsules according to the manufacturer's approved packaging instructions. Keep the medicine in its original packaging and out of reach of children. Follow the product label for handling and disposal precautions.

Frequently Asked Questions

1. What is Lenalid 15mg Capsules?

Lenalid 15mg is an oral capsule formulation containing 15mg of Lenalidomide, an immunomodulatory prescription medicine.

2. What is the generic name of Lenalid 15mg?

The generic name is Lenalidomide.

3. Is Lenalid 15mg a prescription medicine?

Yes. Lenalidomide requires specialist medical supervision and must be used according to applicable prescribing information.

4. What are the important safety precautions?

Important precautions include embryo-fetal toxicity, reduced blood-cell counts and the risk of blood clots. Appropriate clinical monitoring is essential.

5. Where can pharmaceutical professionals request product information?

Eligible healthcare institutions and authorised pharmaceutical trade partners can contact Cordium Pharmaceuticals Pvt Ltd for relevant product and supply documentation.